Previous Article | Next Article ![]()
Journal of Virology, January 1999, p. 767-771, Vol. 73, No. 1
LSU Eye Center, Department of Ophthalmology, Microbiology
and Immunology, and Department of Pharmacology, Louisiana State
University Medical Center School of Medicine, New Orleans, Louisiana
70112-22341;
Ophthalmology Research
Laboratories, Cedars-Sinai Medical Center Burns and Allen Research
Institute, Los Angeles, California 900482;
Jefferson Center for Biomedical Research, Thomas Jefferson
College, Doylestown, Pennsylvania 189013;
and
Department of Ophthalmology, UCLA School of Medicine,
Los Angeles, California 900244
Received 25 August 1998/Accepted 13 October 1998
The herpes simplex virus type 1 (HSV-1) LAT gene is the only viral
gene abundantly transcribed during latency. LAT null mutants created
with strains McKrae and 17syn+ are impaired for both in vivo
spontaneous and in vivo-induced reactivation. Thus, LAT is essential
for efficient in vivo-induced and spontaneous reactivation. Different
investigators have studied two LAT mutants containing a
StyI-StyI region deletion corresponding to LAT
nucleotides 76 to 447. One mutant, dLAT371 (parent strain,
McKrae), had parental high frequencies of spontaneous reactivation. In
vivo-induced reactivation was not examined. The other mutant, 17 Herpes simplex virus type 1 (HSV-1)
can infect the eye, after which it travels by retrograde axonal
transport to the trigeminal ganglia and establishes a latent infection
that lasts throughout the life of the infected individual. The virus
can reactivate sporadically, return to the eye, and cause recurrent
disease. This in turn can produce corneal scarring leading to loss of
vision. In the industrialized nations, recurrent ocular HSV-1 is the
leading cause of infectious corneal blindness (16).
The only viral gene abundantly transcribed during latency is the
latency-associated transcript (LAT) (21, 24). LAT is located
in the long repeats of the HSV-1 genome and is therefore present in two
copies per genome (Fig. 1). LAT is
transcribed as an 8.3-kb RNA that gives rise to a family of LAT RNAs,
including a very stable 2.0-kb LAT intron (5, 23, 26-28).
LAT null mutants incapable of LAT transcription reactivate poorly by
explant culture or induced reactivation in the mouse (12, 13,
22), by induced reactivation in the rabbit(2, 10, 25),
and by spontaneous reactivation in the rabbit (1, 9, 17,
18).
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identical 371-Base-Pair Deletion Mutations in the LAT Genes of
Herpes Simplex Virus Type 1 McKrae and 17syn+ Result in Different
In Vivo Reactivation Phenotypes
![]()
ABSTRACT
Top
Abstract
Text
References
Sty
(parent strain, 17syn+), had parental frequencies of in vitro
reactivation following cocultivation of explanted ganglia but reduced
frequencies of in vivo-induced reactivation. Spontaneous reactivation
frequency was not reported for 17
Sty. These combined results
suggested the possibility that in vivo spontaneous reactivation and in
vivo-induced reactivation may map to different regions within the LAT
domain. We now report that dLAT371 has in vivo-induced
reactivation frequencies of the parent and that 17
Sty has reduced
frequencies of in vivo spontaneous reactivation. Thus,
dLAT371 demonstrated the parental phenotype for both in
vivo spontaneous and -induced reactivation while the apparently
identical 17
Sty was impaired for both in vivo spontaneous and
-induced reactivation. These results suggest that one or more
differences between the genetic backgrounds of McKrae and 17syn+ result
in different in vivo reactivation phenotypes of otherwise identical
deletion mutations and that McKrae may have compensating sequences
sufficient to overcome the loss of the
StyI-StyI region of the LAT transcript.
![]()
TEXT
Top
Abstract
Text
References

View larger version (14K):
[in a new window]
FIG. 1.
Structures of dLAT371 and 17
Sty. The top
of the figure shows a schematic representation of the prototypic
orientation of HSV-1 (strains McKrae and 17syn+). HSV-1 contains a
unique long region and a unique short region, each of which is flanked
by inverted repeats. The unique regions are shown as solid lines. The
repeats are shown as open rectangles. UL, unique long;
US, unique short; TRL, terminal repeat, long;
IRL, internal repeat, long; TRS, terminal
repeat, short; IRS, internal repeat, short. The long-repeat
regions are expanded to show details of the LAT domain and are
indicated by the dashed lines. The locations of the genes for ICP0 and
ICP34.5 are shown for reference. (A) Detailed enlargement of the
internal-repeat region of parental and marker-rescued viruses. This
region contains the 8.3-kb primary LAT transcript. The direction of
transcription is indicated by the arrowhead. TATA indicates the
location (in the genomic DNA) of the LAT promoter TATA box. The start
of LAT transcription is indicated as +1, corresponding to nt 118801 of
the genome (15, 20). The filled rectangle within the primary
8.3-kb LAT transcript indicates the location of the stable 2-kb LAT
intron starting at LAT nt 662. The locations and directions of the
ICP34.5 and ICP0 transcripts are shown for reference. In all viruses
shown here, the copy of LAT in the terminal long repeat is identical to
the internal long repeat (enlargement shown). (B) dLAT371, a
McKrae mutant. The 371-nt deletion is indicated by the break in the
line and is bounded by the StyI restriction sites at LAT nt
76 and 447. This deletion is present in both copies of LAT (one in each
long repeat). (C) 17
Sty, a 17syn+ mutant. The
StyI-StyI deletion is identical to that shown in
panel B. (D) dLAT2903, a McKrae LAT null mutant. The
deletion from nt
161 to +1667 encompasses part of the LAT promoter
containing the TATA box. The region of LAT downstream of the
HpaI site is drawn with a dashed line to indicate that
dLAT2903 makes no LAT RNA.
In a previous study, the HSV-1 McKrae-based mutant dLAT371
(Fig. 1B) with a deletion of a 371-nucleotide (nt)
StyI-StyI region corresponding to LAT nt 76 to
447 did not affect in vivo spontaneous reactivation in the rabbit
ocular model (19). This finding suggests that this region is
not essential for efficient spontaneous reactivation. In vivo-induced
reactivation was not examined in that study. 17
Sty (Fig. 1C), a
mutant constructed from HSV-1 17syn+ that had the same
StyI-StyI deletion as dLAT371
(14), reactivated poorly in the rabbit ocular model
following induced in vivo reactivation by iontophoresis of epinephrine
(7). 17
Sty-Res (Fig. 1A), the rescued 17
Sty mutant,
had the high-reactivation phenotype of the parent, 17syn+. Spontaneous
reactivation of 17
Sty was not reported at that time. Thus, in vivo
spontaneous reactivation of dLAT371 is at the parental
frequency while in vivo-induced reactivation of 17
Sty is reduced.
The present study was directed at determining if dLAT371,
like 17
Sty, is impaired for in vivo-induced reactivation and if 17
Sty, like dLAT371, exhibits the parental phenotype for
in vivo spontaneous reactivation. If so, these findings may indicate
that in vivo-induced reactivation and in vivo spontaneous reactivation are due to different LAT gene functions. If, however,
dLAT371 has the McKrae phenotype for in vivo-induced
reactivation and 17
Sty is impaired for spontaneous reactivation,
there may be a difference between HSV-1 strains McKrae and 17syn+, such
that McKrae is able to compensate for a deletion of 371 nt within the LAT gene.
A genetic map of the viruses used in this report is shown schematically
in Fig. 1. The top of Fig. 1 illustrates the HSV-1 genome of both
McKrae and 17syn+. In each virus, both copies of LAT (one in each long
repeat) are identical. For simplicity, in Fig. 1A to D, only an
enlargement of the internal long repeat region is shown. Panel A shows
the LAT region of both wild-type parental viruses and the
marker-rescued viruses, dLAT371R (19), dLAT2903R (17), and 17
Sty-Res (14),
that have been restored back to the parental phenotype. Panels B and C
show the LAT regions of the McKrae-based dLAT371 and the
17syn+-based 17
Sty, respectively. Both viruses contain a
StyI-StyI deletion in both copies of their LAT
genes and are otherwise structurally unaltered from their parents
(14, 19). The LAT promoters in dLAT371 and
17
Sty are intact, and both mutants appear to have normal LAT
expression and RNA processing despite the fact that the primary LAT
transcript is 371 nt shorter. Panel D shows dLAT2903, a
McKrae-based LAT null mutant that contains a deletion of LAT nt
161
to +1667 relative to the transcription start sites in both copies of
the LAT gene. This mutant does not transcribe any detectable LAT RNA
and has previously been shown to be impaired for both in vivo
spontaneous and -induced reactivation in latently infected rabbits
(17).
To ensure that any differences seen between dLAT371 and
17
Sty were not due to subtle differences in the rabbit model
employed by the two testing laboratories, dLAT371
(constructed and analyzed for spontaneous reactivation by Perng et al.
[19]) was sent to the Hill laboratory (the original
analysis of 17
Sty was by Hill et al. [7]). To
examine in vivo spontaneous and -induced reactivation, rabbits were
infected with either dLAT371 or 17
Sty, their parent
viruses McKrae or 17syn+ (positive controls), dLAT2903 (negative control), or the rescuant of 17
Sty (17
Sty-Res).
Inoculations with the McKrae viruses were done in unscarified eyes,
since McKrae infects unscarified eyes with very high efficiency.
Inoculations with the 17syn+ viruses were done in mildly scarified eyes
(2 by 2 crosshatch), to increase the efficiency of the acute infection. Kaufman et al. (11) and Garza and Hill (6) used
scarification to infect with McKrae to allow for the synchronization of
the initial times the lesions appeared. They did not use scarification when inoculating with 17syn+ and saw similar levels of severity of the
lesions with only an alteration in the time interval to the
visualization of the lesions. Scarification prior to acute infection
does not alter reactivation. The rabbits received 2 × 105 PFU of virus in a 25-µl suspension of tissue culture
medium. The acute infection was monitored by slit-lamp microscopy until all eyes demonstrated dendritic lesions (postinoculation [p.i.] days
4 through 7 [7]). Rabbits were considered latently
infected when the epithelium recovered from the corneal lesion (p.i.
day 21). Latently infected rabbits were allowed to reactivate
spontaneously or were induced to reactivation by epinephrine
iontophoresis. In either case, a tear film was collected daily from
each eye and incubated in tubes containing indicator (primary rabbit
kidney) cells for detection of cytopathic effect (7, 8).
To examine in vivo spontaneous reactivation, rabbits were inoculated as
described above. Cohorts of latently infected rabbits were established
as described above, and spontaneous reactivation was analyzed as
previously described (1). The numbers of rabbits, eyes, and
swabs tested are shown in Table 1 with
respect to the number of positive results over the total number of
specimens tested for each parameter. The data shown are totals from two experiments, which produced similar results. Spontaneous reactivation of 17
Sty was significantly reduced compared to that of 17syn+ with
respect to rabbits (P = 0.03), eyes (P = 0.0005), and swabs (P = 0.0001). The parental
phenotype was restored in the marker-rescued strain 17
Sty-Res
(rabbits and eyes, P = 1.0; swabs, P = 0.53). Thus, the StyI-StyI deletion in
17
Sty causes impaired in vivo spontaneous reactivation compared to
that of 17syn+.
|
The reduced spontaneous reactivation frequencies for 17
Sty shown in
Table 1 differ from data previously reported for dLAT371, which had the parental phenotype for spontaneous reactivation. For
comparison purposes, previous results for McKrae, dLAT371, and dLAT2903 (19) are also reported in Table 1.
McKrae and 17syn+ had similar frequencies of spontaneous reactivation
(rabbits, P = 0.62; eyes, P = 1.0;
swabs, P = 0.42). In contrast, spontaneous reactivation
of dLAT371 and 17
Sty were significantly different (rabbits, P = 0.04; eyes, P = 0.0008;
swabs, P < 0.0001). Furthermore, the reduced
spontaneous reactivation of 17
Sty appeared similar to the reduced
spontaneous reactivation of dLAT2903 (Table 1). These
findings confirm that dLAT371 and 17
Sty have different spontaneous reactivation phenotypes and indicate that spontaneous reactivation of the 17
Sty mutant is similar to that of
dLAT2903, a LAT null mutant.
The numbers of rabbits, eyes, and swabs tested for in vivo-induced reactivation are shown in Table 2 with respect to the number of positive results over the total number of specimens tested. Within all three parameters (rabbits, eyes, and swabs), the in vivo-induced reactivation of dLAT371 was not statistically different than that of McKrae but was significantly greater than that of dLAT2903 (Table 2). Thus, in vivo-induced reactivation of dLAT371 did not appear to be reduced. As previously shown by Perng et al. (17), the LAT null mutant dLAT2903 had significantly reduced in vivo-induced reactivation compared to that of the parent McKrae (Table 2) when results for eyes and swabs were compared. The data from rabbits latently infected with dLAT2903 were not significantly different from data for rabbits latently infected with McKrae, and this is probably due to the smaller than usual number of latently infected McKrae rabbits that were induced to reactivate.
|
The results shown in Table 2 indicate that dLAT371 was
induced by epinephrine iontophoresis to reactivate. 17
Sty had
significantly reduced reactivation by epinephrine iontophoresis
compared to that of its parent virus, 17syn+ (7). For
comparison purposes, the previous 17
Sty results are also shown in
Table 2. While McKrae and 17syn+ had similar induced reactivation
frequencies as evidenced by the swab data (P = 0.2) and
rabbit and eye data (P = 1.0), dLAT371 and
17
Sty were significantly different with respect to the swab data
(P < 0.0001) and rabbit and eye data (P = 0.003). Furthermore, the induced reactivation frequency of 17
Sty was similar to that of dLAT2903 (P > 0.7), both of which were reduced. These findings indicate that
dLAT371 and 17
Sty have different induced reactivation
phenotypes and that in vivo-induced reactivation of 17
Sty is similar
to that of the LAT null mutant dLAT2903.
The McKrae-based mutant dLAT371 and the 17syn+-based mutant
17
Sty have identical deletions of the
StyI-StyI region within the 5' end of the primary
LAT transcript. The structures of both mutants were confirmed by
Southern blot analysis (7, 14, 19). Both mutants appear to
be unimpaired for LAT transcription, with the exception of a smaller
transcript, due to the deletion of LAT nt 76 to 447. The sequences for
the first 1.5 kb of the LAT genes in McKrae and 17syn+ are very
similar, with approximately 98% identity (4). Their
StyI-StyI subregions (LAT nt 76 to 447) have a
similar level of homology. Within this region, compared to McKrae,
17syn+ has nine mismatched nucleotides, one inserted nucleotide, and
one deleted nucleotide, for an overall nucleotide homology of 97%.
Without atypical splicing, there are no well-conserved potential open
reading frames in this region of LAT (4). Furthermore, both
mutants appear to have their respective parental wild-type phenotypes
for in vitro and in vivo replication, acute eye disease, neurovirulence, and rate at which latency is established
(7). In addition, the results reported here indicate that
the apparent in vivo reactivation differences between results for the
dLAT371 and 17
Sty mutants from the two laboratories were
not due to analysis of in vivo spontaneous reactivation by one
laboratory and analysis of in vivo-induced reactivation by the second
laboratory. The results were also not due to differences in the
techniques or methodologies used by the laboratories analyzing the
mutants. It therefore appears that the difference between the in vivo
reactivation phenotypes of these otherwise identical mutants was due to
genotypic differences in the parental strains.
The finding that the StyI-StyI region of LAT in
strain 17syn+ is essential for in vivo-induced reactivation but that
this region of LAT in strain McKrae is not essential for this function was unexpected. Since the StyI-StyI region of LAT
in 17syn+ plays a role in in vivo reactivation, it is likely that this
region is also important in McKrae; however, we found that
StyI-StyI is not necessary for induced
reactivation in strain dLAT371. This is not the first
reported paradox found in HSV reactivation experiments. Bloom et al.
(3) reported that a 348-bp deletion in 17syn+ has reduced in
vivo-induced reactivation frequencies. In attempting to define the
region responsible for the phenotype, three shorter, nonoverlapping
deletion mutants were generated (17
110, 17
91, and 17
116) from
the 348-bp deletion. These viral constructs had the high in vivo
reactivation frequencies of the parent strain, 17syn+ (3).
To date, this paradox is not fully understood and new constructs are
being generated and additional experiments are being planned. Our
findings here suggest that the McKrae background can compensate for the
loss of this region in the LAT gene. The compensatory genomic region
may lie either within LAT or elsewhere in the genome. However, since
LAT has been shown to be essential for parental frequencies of
spontaneous reactivation in McKrae, it is likely that the compensatory
region lies within LAT. One possibility is that, at least in McKrae,
the LAT domain has multiple functional regions. These regions need not
all be present to achieve parental in vivo reactivation frequencies.
Also, based on the data from 17
348, 17
Sty, and
dLAT371, it is evident that small manipulations of the HSV-1
genome are enough to disturb the in vivo reactivation phenotypes of
these viruses. This hypothesis would help explain why natural selection
has resulted in conservation of the entire 8.3-kb primary LAT
transcript in all HSV-1 strains examined, despite the finding that just
the first 1.5 kb of this transcript is sufficient for high frequencies
of spontaneous reactivation in rabbits (18).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grants EY07566 (S.L.W.), EY10243 (S.L.W.), EY06311 (J.M.H.), and EY02377 (Eye Core Grant); Research to Prevent Blindness; the Discovery Fund for Eye Research; and the Skirball Program in Molecular Ophthalmology.
We thank Maxine Simpson-Evans for expert technical support.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Ophthalmology Research Laboratories, Cedars-Sinai Medical Center Burns and Allen Research Institute, Davis Bldg., Room 5072, 8700 Beverly Blvd., Los Angeles, CA 90048. Phone: (310) 855-6457 or (310) 855-6455. Fax: (310) 652-8411. E-mail: Wechsler{at}CSMC.EDU.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Berman, E. J., and J. M. Hill.
1985.
Spontaneous ocular shedding of HSV-1 in latently infected rabbits.
Investig. Ophthalmol. Vis. Sci.
26:587-590 |
| 2. |
Bloom, D. C.,
G. B. Devi-Rao,
J. M. Hill,
J. G. Stevens, and E. K. Wagner.
1994.
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo.
J. Virol.
68:1283-1292 |
| 3. | Bloom, D. C., J. M. Hill, G. Devi-Rao, E. K. Wagner, L. T. Feldman, and J. G. Stevens. 1996. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70:2449-2459[Abstract]. |
| 4. | Drolet, B. S., G. C. Perng, J. Cohen, S. M. Slanina, A. Yukht, A. B. Nesburn, and S. L. Wechsler. 1998. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242:221-232[Medline]. |
| 5. |
Farrell, M. J.,
A. T. Dobson, and L. T. Feldman.
1991.
Herpes simplex virus latency-associated transcript is a stable intron.
Proc. Natl. Acad. Sci. USA
88:790-794 |
| 6. | Garza, H. H., Jr., and J. M. Hill. 1997. Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits. Curr. Eye Res. 16:453-458[Medline]. |
| 7. |
Hill, J. M.,
J. B. Maggioncalda,
H. H. Garza, Jr.,
Y.-H. Su,
N. W. Fraser, and T. M. Block.
1996.
In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5' end of the 2.0-kilobase latency-associated transcript.
J. Virol.
70:7270-7274 |
| 8. | Hill, J. M., R. J. O'Callaghan, and J. A. Hobden. 1993. Ocular iontophoresis, p. 331-354. In A. K. Mitra (ed.), Ophthalmic drug delivery systems. Marcel Dekker, Inc., New York, N.Y. |
| 9. | Hill, J. M., F. Sederati, R. T. Javier, E. K. Wagner, and J. G. Stevens. 1990. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117-125[Medline]. |
| 10. | Hill, J. M., R. Wen, and W. P. Halford. 1998. Pathogenesis and molecular biology of HSV latency and ocular reactivation in the rabbit, p. 291-315. In M. S. Brown, and A. R. Maclean (ed.), Herpes simplex virus protocols. Humana Press, Inc., Totowa, N.J. |
| 11. | Kaufman, H. E., E. D. Varnell, B. M. Gebhardt, H. W. Thompson, and J. M. Hill. 1996. Propanolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit. Curr. Eye Res. 15:680-684[Medline]. |
| 12. |
Leib, D. A.,
C. L. Bogard,
M. Kosz-Vnenchak,
K. A. Hicks,
D. M. Coen,
D. M. Knipe, and P. A. Schaffer.
1989.
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.
J. Virol.
63:2893-2900 |
| 13. |
Leib, D. A.,
K. C. Nadeau,
S. A. Rundle, and P. A. Schaffer.
1991.
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.
Proc. Natl. Acad. Sci. USA
88:48-52 |
| 14. |
Maggioncalda, J.,
A. Mehta,
N. W. Fraser, and T. M. Block.
1994.
Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript.
J. Virol.
68:7816-7824 |
| 15. |
McGeoch, D. J.,
M. A. Dalrymple,
A. J. Davison,
A. Dolan,
M. C. Frame,
D. McNab,
L. J. Perry,
J. E. Scott, and P. Taylor.
1988.
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.
J. Gen. Virol.
69:1531-1574 |
| 16. |
Nesburn, A. B. (ed.).
1983.
Report of the corneal disease panel: vision research a national plan, 1983-1987. II, part III.
C. V. Mosby, St. Louis, Mo.
|
| 17. |
Perng, G.-C.,
E. C. Dunkel,
P. A. Geary,
S. M. Slanina,
H. Ghiasl,
R. Kaiwar,
A. B. Nesburn, and S. L. Wechsler.
1994.
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
J. Virol.
68:8045-8055 |
| 18. | Perng, G.-C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70:976-984[Abstract]. |
| 19. | Perng, G.-C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70:2014-2018[Abstract]. |
| 20. |
Perry, L. J., and D. J. McGeoch.
1988.
The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1.
J. Gen. Virol.
69:2831-2846 |
| 21. |
Rock, D. L.,
A. B. Nesburn,
H. Ghiasl,
J. Ong,
T. L. Lewis,
J. R. Lokensgard, and S. L. Wechsler.
1987.
Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.
J. Virol.
61:3820-3826 |
| 22. |
Sawtell, N. M., and R. L. Thompson.
1992.
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.
J. Virol.
66:2157-2169 |
| 23. |
Spivack, J. G., and N. W. Fraser.
1988.
Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.
J. Virol.
62:1479-1485 |
| 24. |
Stevens, J. G.,
E. K. Wagner,
G. B. Devi-Rao,
M. L. Cook, and L. T. Feldman.
1987.
RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons.
Science
235:1056-1059 |
| 25. |
Trousdale, M. D.,
I. Steiner,
J. G. Spivack,
S. L. Deshmane,
S. M. Brown,
A. R. MacLean,
J. H. Subak-Sharpe, and N. W. Fraser.
1991.
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.
J. Virol.
65:6989-6993 |
| 26. |
Wechsler, S. L.,
A. B. Nesburn,
R. Watson,
S. M. Slanina, and H. Ghiasi.
1988.
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames.
J. Virol.
62:4051-4058 |
| 27. |
Wechsler, S. L.,
A. B. Nesburn,
R. Watson,
S. M. Slanina, and H. Ghiasi.
1988.
Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans.
J. Gen. Virol.
69:3101-3106 |
| 28. |
Zwaagstra, J. C.,
H. Ghiasi,
S. M. Slanina,
A. B. Nesburn,
S. C. Wheatley,
K. Lillycrop,
J. Wood,
D. S. Latchman,
K. Patel, and S. L. Wechsler.
1990.
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript.
J. Virol.
64:5019-5028 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|